Astellas Pharma Inc. Site Map
 
Home > Therapeutic Areas > Products > U.S. Marketed Products
   
U.S. Marketed Products

Following is a list of Astellas' products marketed in the U.S. This information is intended for U.S. residents only.

Cardiology

Adenoscan® (adenosine injection)

Adenocard® (adenosine injection)

Lexiscan® (regadenoson)

Vaprisol® (conivaptan)

Dermatology

Protopic® (tacrolimus) Ointment

Amevive® (alefacept)

Immunology

Prograf® (tacrolimus)

Infectious Disease

AmBisome® (amphotericin B) liposome for injection

MYCAMINE® (micafungin sodium) for injection

VIBATIVTM (telavancin)


Neuroscience

SUMAVELTM DoseProTM (sumatriptan injection) Needle-free delivery system

Urology

VESIcare® (solifenacin succinate)**

Adenocard® is a registered trademark of Astellas Pharma US, Inc.

Lexiscan® is a registered trademark of Astellas U.S. LLC.

Vaprisol® is a registered trademark of Astellas Pharma Inc. INTRAVIA® is a registered trademark of Baxter International, Inc. (only should be used when referencing Vaprisol (conivaptan hydrochloride injection) Premixed in 5% Dextrose).

Protopic® is a registered trademark of Astellas Pharma Inc.

Amevive® is a registered trademark of Astellas U.S. LLC.

Prograf® is a registered trademark of Astellas Pharma Inc.

AmBisome® is a registered trademark of Gilead Sciences, Inc.

Mycamine® is a registered trademark of Astellas Pharma Inc.

SUMAVEL and DosePro are trademarks of Zogenix, Inc.
SUMAVELTM DoseProTM is co-promoted with Astellas Pharma U.S., Inc. in the U.S.

VESIcare® is a registered trademark of Astellas Pharmaceuticals Inc. VESIcare® is co-promoted with GlaxoSmithKline in the U.S.

VIBATIVTM (telavancin) is a registered trademark of Astellas Pharma Inc.

   
Copyright © 2005 - 2009 Astellas Pharma US, Inc. Site Map  Privacy Policy  Legal Disclaimer  Contact Us